ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Cinqaero 25 mg/2,5 mL, Konzentrat zur Herstellung einer Infusionslösung - 
66340002 Teva Pharma AG
Cinqaero 25 mg/2,5 mL, Konzentrat zur Herstellung einer Infusionslösung09.11.2017
  12.07.2018
Reslizumab (R03DX08) 
WHO-DDD 
03.04.50. 
03.04.50. 
B  
Yes 
IP 
141.81Yes
    
10 %179.35
7680663400022Biotechnologika
7557993 
Composition
reslizumabum 25 mg, saccharum, natrii acetas trihydricus, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 2.5 ml corresp. natrium 0.35 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Reslizumabum25mg / 2.5ml
BAG: Active AgentDose
Reslizumabum25 mg
 
Inactive agents
Acidum Aceticum Glaciale
Sodium Acetate Trihydrate
Saccharum
 
Source
Data was imported : 08.06.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home